chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Warmth at the injection site; Induration at the injection site; Erythema at the injection site; This spontaneous case was reported by a health care professional and describes the occurrence of VACCINATION SITE WARMTH (Warmth at the injection site), VACCINATION SITE INDURATION (Induration at the injection site) and VACCINATION SITE ERYTHEMA (Erythema at the injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE WARMTH (Warmth at the injection site), VACCINATION SITE INDURATION (Induration at the injection site) and VACCINATION SITE ERYTHEMA (Erythema at the injection site). At the time of the report, VACCINATION SITE WARMTH (Warmth at the injection site), VACCINATION SITE INDURATION (Induration at the injection site) and VACCINATION SITE ERYTHEMA (Erythema at the injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication details not reported by the reporter. Treatment details not reported by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 25-Mar-2021: Updated outcome of the events from unknown to recovered.
Within 15 minutes of taking my 1st dose my neck felt weird like cramping. I had to visit the Doctor because my neck swelled up and the pain is quite strong. It was stated to me that it was a Lymph node. With the 2nd dose it got worse and with the 3rd dose I have itching on my arm, a red lump that doesn't go down and a fairly large nodule on my neck. It huts a lot and to tell you the truth since the 1rst dose the inflammation has not gone down and it comes and goes only that in this 3rd dose the neck area hurts a lot more with today I have been vaccinated with my 3rd dose for 5 days, and I feel very tired and that is not normal. I am worried  about my salt.
Redness at injection site (observed by myself and Dr at urgent care facility). Pt describes extreme soreness and oozing.
13 doses administered 25Oct2021/this lot number has an expiration date of 10/24/2021; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (13 doses administered 25Oct2021/this lot number has an expiration date of 10/24/2021) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 24-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .25 milliliter. On 25-Oct-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (13 doses administered 25Oct2021/this lot number has an expiration date of 10/24/2021). On 25-Oct-2021, EXPIRED PRODUCT ADMINISTERED (13 doses administered 25Oct2021/this lot number has an expiration date of 10/24/2021) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 28-Oct-2021: Follow Up received includes no new information.
Information has been received from a medical assistant concerning a 16 year old female who on 23-APR-2007 was vaccinated with GARDASIL vaccine (yeast) (lot #657005/0314U). On 23-APR-2007 the patient experienced nausea and feeling out of it. The patient did not seek medical attention. Subsequently, the patient recovered from nausea and feeling out of it. A case was filed for the patient's sister with the same events for WAES #0710USA02783. No further information was provided. Additional information has been requested.
Myalgias, proximal LE weakness and pain. Onset 5-6 hours after injection. TX Medrol DP 24 mg Taper to 0 over 7day.
light headedness; A spontaneous report was received from a consumer concerning a 58-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events light headedness/dizziness.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 4 Feb 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: 012L20A) intramuscularly in unknown for prophylaxis of COVID-19 infection.  On 4 Feb 2021, the patient experienced the event light headedness.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   On 8 Feb 2021, the outcome of event light headedness was unknown.
14Jan rash on chest &abdomen X 1 wk,18Jan seen by MD,eyes red,denies itching,21Jan @ 300pm awakened /c chest pain,sweating, hands numb, Seen by MD @ 800am, Con't to have problems /w numbness &pain in hands become red /w fullness in chest.
Shingles outbreak on back of neck; Genital herpes outbreak; This is a spontaneous report from a non-contactable consumer, the patient. A 35-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 03Apr2021 at 15:15 (at the age of 34-year-old) as a single dose for COVID-19 immunisation. Medical history included shingles. The patient did not have any allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The patient did not receive any medications within two weeks of the COVID-19 vaccine. On 04Apr2021 at 12:00, the patient experienced genital herpes outbreak within 24 hours of vaccination. The patient stated that he did not treat it with medication. On 19Apr2021, the patient experienced shingles outbreak on back of neck, 15 days after vaccination. Patient stated that he had shingles previously as an adult and also as a child. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the event shingles outbreak on back of neck and included treatment with valacyclovir. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of events genital herpes outbreak, shingles outbreak on back of neck was recovering at the time of this report. The patient also received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the left arm on 24Apr2021 at 15:15 (at the age of 34-year-old) as a single dose for COVID-19 immunisation.  No follow-up attempts are possible. No further information is expected.
pt recv vax 11SEP97 pt had swollen areas both eyes-shut today;no fever later this day, had rash, face cheeks;pt was taken to family MD for tx;
This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. No medical history and concurrent conditions were reported. On 24-JUN-2016 the patient was inadvertently vaccinated with an expired dose of ZOSTAVAX vial 19400 PFU (lot # L003215, 30-APR-2016) (dosing regimen and frequency unknown) subcutaneously. No concomitant medications were reported. No adverse effects were reported. The action taken with the therapy with ZOSTAVAX was unknown. The outcome of the events was unknown. There was no product quality complaint reported. Additional information has been requested.
On 3/8/01 at 20:00, had grand mal seizure when lying in grandmother's lap, 30 minutes after a bath. Head went back, eyes rolled back, clonic movements all extremities and cyanotic. Grandmother gave CPR. All of episode lasting 3-5 minutes. He was lethargic afterwards. No fever. Saw in ER. On 3/11/01, 30 minutes after a bath, had a grand mal seizure. No CPR. Seen in ER and hospitalized 3 days. On 3/12/01, had a seizure lasting 1-2 minutes. Dx'd with epilepsy. Put on Phenobarbital.
headaches, dizziness, coordination loss, loss of some ability to concentrate, upset stomach, heart burn, always cold no matter the outside temp, no motivation to do anything, body ache,  more than usual joint pain,
I have rash that got progressively worse started at left side of my neck and to front then to right side going up my chin. It?s hot to touch and painful fever also with this. Nothing has been done different just the last vaccination.
Sore arm  Headache  Menstrual period 3 weeks early  Heavy menstrual bleeding  Cramps in lower back and abdomen
Information has been received from a consumer concerning her 17 year old daughter who on 11-JUL-2007, 20-SEP-2007, 26-JAN-2008 was vaccinated with her first, second and third dose of Gardasil, respectively. It was reported that the patient did not have a reaction to the first or second dose. Within two weeks after her third dose she experienced a high fever and blisters down her throat. It was reported that she missed work and school due to the reaction. The consumer's sister also had a similar reaction to Gardasil (WAES#0710USA03615). Additional information has been requested.  follow up 2/12/2010- follow up information received from the physician regarding a 14 year old caucasian female patient (previously reported as 17 years old) with no previous medical history or no illness at the time of vaccination, who on 11-jul-2007. at 10:04 am was vaccinated IM in the left arm with the first dose of HPV 6 11 16 18 vaccine (yeast) (lot# 658100/05250) and on 20-sep-2007 at 6: 46 pm, was vaccinated IM in the left arm with the second dose of HPV 11 16 18 vlp vaccine (yeast) lot# 657736/0389u. on 31-jul-2007, the patient experienced a fever began 2 weeks following the 1st vaccination. also experienced oral ulcers. fever persisted x 1 week. again developed fever and mouth sores 2 weeks following dose 2. no reactions after the third vaccination.  the patient recovered 1-2 weeks after onset of symptoms.
After the administration of the vaccine, hives / rashes with pus appeared on the neck, right arm and back. Initially visited the Urgent Care on April 1, 2021, initially the doctors thought it was dermatitis. The symptoms started to improve in the next two weeks. The second dose was applied on April 10, 2021, after the application the same rashes reappeared on the skin in a more evident way and spread to the legs. It also spread further on the arms, back and face / face (on the face it was not as invasive / aggressive as on the arms and back). I visited Urgent Care again on April 15, 2021 and that was where they indicated that it was an adverse effect to the vaccine. The diagnosis Shingles (Measles).
Abnormally heavy and long menstruation. Menstruation started a whole week early.
Dizziness, Nausea during day after vaccine administration, patient also had insulin administration techniques altered/corrected day previously, lower than average blood sugars could also explain these symptoms.
falling outside of the 42 days to get the second vaccine; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (falling outside of the 42 days to get the second vaccine) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. U11A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (falling outside of the 42 days to get the second vaccine). At the time of the report, PRODUCT DOSE OMISSION ISSUE (falling outside of the 42 days to get the second vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was mentioned. No treatment medication was mentioned.
2 and 3APR93 pt noted by parents to have fever 99 along w/rhinorrhea, loss of appetite & fussiness; 5APR93 mom noted generalized body rash appearing like small, fine pink spots which lasted 3 days & accompanied by fussiness & diarrhea;
Moderna vaccine. A couple hours after recieving the shot I felt very sore all over my body and my joints started hurting worse and worse. It was basically the first cold or flu I hav had in many years. The second dose was much worse. I had extreme neck pain and woke up at 230am With my heart hurting and I was having trouble breathing. I had a bad fever. I felt like death for days. I did throw up the next day but believe that to be because of bad chicken I made the night before. My bowel movements have been different ever since I received the second dose. I don't know where to start with healthcare but this was not it. I did it for my parents and shaming/ travel policing messages. Garbage
Narrative:  Fully COVID vaccinated, positive on admission and passed away due to hypoxic respiratory failure due to COVID
The next day I had red streaks left arm. It lasted for 3-4 days.; This spontaneous case was reported by a patient and describes the occurrence of RASH ERYTHEMATOUS (The next day I had red streaks left arm. It lasted for 3-4 days.) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     The relevant medical history/conditions, allergy, concomitant diseases and risk factor was unknown.   On 08-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Apr-2021, the patient experienced RASH ERYTHEMATOUS (The next day I had red streaks left arm. It lasted for 3-4 days.). At the time of the report, RASH ERYTHEMATOUS (The next day I had red streaks left arm. It lasted for 3-4 days.) had resolved.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment medications were reported.  Reporter did not allow further contact
Pt recvd 2 doses of Engerix-B & 1 day p/2nd dose exp vomiting, nausea, diarrhea for 4 days followed by rash & hives; events are unresolved;
Debilitating migraine lasting 4 days so far, have tried excedrin, ibuprofen, magnesium, and nothing has helped. Had to take a trip to urgent care to get a toradol shot.
Patient was treated for shingles; This initial spontaneous report was received from a lawyer regarding a case in litigation referring to a female patient of unknown age. The patient's pertinent medical history, concurrent conditions or concomitant medications were not reported. On an unspecified date in 2011, the patient was vaccinated with zoster vaccine live(ZOSTAVAX) (lot#, expiration date, dosage and route of administration were not provided) for the long-term prevention of shingles and zoster-related conditions. On an unknown date, subsequent to the patient's vaccination with zoster vaccine live(ZOSTAVAX), the patient was treated by a physician for shingles. As a direct and proximate result of the patient's use of the zoster vaccine live(ZOSTAVAX) vaccine, the patient had and would continue suffering ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies. At the time of the report, the outcome of shingles was unknown. The reporter considered shingles to be related to Zoster Vaccine Live(ZOSTAVAX).
Three days after vaccine Booster, I experienced very severe cramping/spasms in lower abdomen. It felt like my body was trying to eliminate toxins from my system. This lasted approximately 48 hours, gradually subsiding after approximately 10 days. I was also extremely fatigued, and more susceptible than usual to warm temperatures.
Difficulty breathing; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Difficulty breathing) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023C214) for COVID-19 vaccination.     Concomitant products included APIXABAN (ELIQUIS), FLUTICASONE PROPIONATE (PROAIR [FLUTICASONE PROPIONATE]) and ERGOCALCIFEROL (VITAMIN D2) for an unknown indication.    On 24-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-May-2021, the patient experienced DYSPNOEA (Difficulty breathing). The patient was treated with OXYGEN on 25-May-2021 for Difficulty breathing, at an unspecified dose and frequency. At the time of the report, DYSPNOEA (Difficulty breathing) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Incorrect Dose Moderna booster dose administered was 0.5 milliliters. Booster dose should have been 0.25
PT 17 YO AT TIME OF ADMIN. PT WAS <18YO OLD FOR MODERNA VACCINE
This non-serious medically spontaneous report (initial receipt 12-AUG 2014) concerns a female patient who had tenderness and swelling in her armpit on the evening of 04-AUG-2014 following the administration of a pneumonia vaccine which she thought it was PNEUMOVAX (0.5 ml, batch number J009827). She also had plagues, which looked like hive, that were "about 2-3 inches in diameter around the injection site the next day". She also had one plaque that developed the "next day" on her inner arm that was slightly elevated and very red and tender. The plaque on her inner arm had "gone down today". Following the administration of an unspecified tetanus vaccine on an unspecified date, she had an unspecified arm swelled "2 to 3 times it's previous size".  On an unspecified date, the patient received influenza vaccine (manufacturer and batch number not provided). On an unspecified date following the influenza vaccine, the patient developed a "hill" at the injection site. Medical attention was not sought.  Outcome was reported as recovering.   Reporter's comments: The reporter commented that an unspecified pneumonia vaccine was the "harder" of the vaccines to administer to children due to adverse reactions that can develop.  The reporter did not provide any further information about children.
Patient had fever 24 hours after administration but resolved within 48 hours after administration.  Patient also had extreme fatigue and was unable to get out of bed which resolved within 48 to 72 hours after administration.
I started getting bad headaches soon after shot and went to dr. to be told was a migraine.  Woke up blind after a week in my right eye went to dr said I had blood clot and stroke in my eye.  I lost my right eyesight.  One week after that I started having horrible joint pain which I had never had before and they believed the vacine was attacking my immune syste.  I spent 6 days in Hospital to stop symptoms with no real relief.   MY blood sugar and blood pressure were severly high and I couldnt function.  I am still dealing with all of this.
Case received Moderna vaccine x 2. Last dose received on 3/9/2021. Patient developed signs and symptoms of COVID 19 Infection on 8/24/2021. Case was tested positive for COVID 19 on 8/24/2021 and was admitted to Medical Center ED on 8/24/2021 and Case expired while still in the hospital on 8/24/2021.
Headache, Arthralgia, Fever, NauseaVomiting, "splitting headache" chills and cold sweat. Narrative:  symptoms ended 1/13
Information has been received from a licensed visiting nurse (L.V.N.) concerning a 67-year-old retired female who is positive for hepatitis C and has penicillin and morphine allergies, who on 21-JUN-2007 was vaccinated subcutaneously in the left arm with a first dose of Zostavax (Oka/Merck) (lot # 656395/0290U).  There was no illness at the time of vaccination.  Concomitant therapy included aspirin and omega-3 marine triglycerides.  On 22-Jun-2007, the patient developed an area of redness and swelling at the injection site the size of a golf ball with pain.  Unspecified medical attention was sought.  No laboratory or diagnostic tests were ordered.  On an unspecified date the patient recovered.  This is one of several reports from the same source.  Additional information is not expected.
my son has covid bad; my son has covid bad; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID: (005570). The reporter is the parent.  A male patient received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant), outcome "unknown" and all described as "my son has covid bad".  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
pt recv vax;4-5 mins p/ vax, became pale, lethargic, diaphoretic, clammy skin,lips blue;BP 80/55;P=88 & strong;given O2,no wheezing;no LOC,pt was hypo responsive;episode resolved completely p/ 30 mins;
Got the first dose March never able to get the second shot and two days after the vaccination tingling legs and arms and legs and head aches and weakness in legs. 03/13/2021 numbness in feet and hands and progressive got worse and went to urgent care 03/17/2021 urine retention and pain back continued to get worse. Urgent care was advised to ride out the feelings. After the urgent care which approximately three weeks she felt better so email the rheumatologist and advised that she see infection specialist prior to second dose but because of the timeframe she went to her second appointment and explained the first dose experience and reaction and the consulted with the site specialist and she was advised to get medical clearance prior to second dose. Saw a infection disease doctor approximately, 05/19/2021 signs of symptoms of case of Guillain-Barre symptom and neurological work up no nerve damage. Was not cleared for second vaccination and neurology agreed. Her DR. each out to the CDC and they were under agreement.
had bladder infection; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 14Mar2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: CYSTITIS (non-serious), outcome "unknown", described as "had bladder infection".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.